Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02925962 · ClinicalTrials.gov registry record · NA

Evaluation of an Electronic CKD Clinical Decision Support System (CDSS) in Clinical Care

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
542
Enrollment target

NCT02925962: Completed NA study, sponsored by University of California, San Francisco.

NCT02925962 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 542 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02925962, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
542 participants
Enrollment target

Study Summary

The investigators propose a three-arm, pragmatic, cluster-randomized clinical trial based in primary care. Participating Primary Care Providers (PCPs) will be randomized to usual care or one of two intervention arms. The first intervention will evaluate the efficacy of an automated CDSS that utilizes the electronic health record (EHR) to facilitate triple marker test ordering, guideline implementation and BP management, compared with usual care, among patients with previous documentation of eGFRcreat \<60 ml/min/1.73m2. The second intervention goes a step further, and will evaluate whether a CDSS plus a follow-up telephone call from a pharmacist (CDSS PLUS) can improve BP management and patient CKD and NSAID toxicity knowledge among the patients with CKD, compared with CDSS alone. The primary clinical outcome is BP level, with secondary outcomes related to processes of care and patient knowledge.

Primary Outcome

Clinical Outcome: The primary clinical outcome of the trial is change in blood pressure (mmHg) from enrollment to the end of the follow up period as a continuous outcome, ascertained from the electronic medical record. BP measures from the clinical record will be ascertained in no more than quarterly intervals in the primary care setting to avoid bias by ascertainment. Investigators will also consider the dichotomous clinical outcome "achieved sustained BP control", defined as BP \< 140/90 mmHg

Interventions

  • OTHER Clinical Decision Support System (CDSS)
  • OTHER Clinic Decision Sup System + Pharmacist

Trial Details

FieldValue
Enrollment Target 542 participants
Start Date 2017-08-14
Est. Completion 2020-06-30
Phase NA

What the finished NCT02925962 record still lists

NCT02925962 is an interventional study that assigns participants to a tested intervention. The registered 542 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower).

The record links to 0 conditions, and to 2 interventions - of which Clinical Decision Support System (CDSS) is the first listed.

NCT02925962 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02925962 about?

NCT02925962 is a clinical study titled "Evaluation of an Electronic CKD Clinical Decision Support System (CDSS) in Clinical Care". The investigators propose a three-arm, pragmatic, cluster-randomized clinical trial based in primary care. Participating Primary Care Providers (PCPs) will be randomized to usual care or one of two intervention arms. The first intervention will evaluate the efficacy of an automated CDSS that utilize...

What is the current status of trial NCT02925962?

This trial is currently completed. It is a NA study. The enrollment target is 542 participants. The study started on 2017-08-14. Estimated completion is 2020-06-30.

What interventions are being tested in trial NCT02925962?

The interventions under investigation include: Clinical Decision Support System (CDSS) (OTHER), Clinic Decision Sup System + Pharmacist (OTHER).

Who is sponsoring clinical trial NCT02925962?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02925962's enrollment target sits among peer trials

542 187th of 2000 higher than 1,814 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04929223 · 542 participants · Phase 1

    A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

  • NCT05584670 · 542 participants · Phase 1

    A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

  • NCT07294053 · 543 participants · NA

    Sugary Drink Labeling Study

  • NCT03127761 · 544 participants

    Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02925962, the US trial registry maintained by the National Library of Medicine. NCT02925962 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.